Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Luporini

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
La Radiologia Medica|July 1, 1976
[Chemotherapy of malignant lymphomas]G Luporini
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
5-fluorouracil cardiotoxicity: the risk of rechallengeR Labianca, G Luporini
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1971
[Antilymphocyte globulins and neoplastic disease]D Mazzei, G Luporini
Giornale Italiano Di Chemioterapia|January 1, 1982
[The use of oral futraful as secondary treatment of patients with metastatic carcinoma]R Labianca, G Beretta, G Luporini
Journal of Surgical Oncology. Supplement|January 1, 1993
Medical treatment of hepatocellular carcinomaG Luporini, R Labianca, G Pancera
Journal of Surgical Oncology. Supplement|January 1, 1991
Chemotherapy for patients not benefitting from 5-fluorouracil therapyG Luporini, R Labianca, G Pancera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Factors influencing response rates for advanced colorectal cancer chemotherapyR Labianca, G Pancera, G Luporini
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Cisplatinum based chemotherapy: role of the antiserotoninergic ondansetron in prevention of emesisM C Locatelli, A D'Antona, G Luporini
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report)G Luporini, P Fraschini, R Labianca, et al.
Lancet (London, England)|April 2, 1977
Carcinoembryonic antigen revisitedG Luporini, P Fraschini, R Labianca, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
La Radiologia Medica|July 1, 1976
[Chemotherapy of malignant lymphomas]G Luporini
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1991
5-fluorouracil cardiotoxicity: the risk of rechallengeR Labianca, G Luporini
Bollettino Dell'Istituto Sieroterapico Milanese|May 1, 1971
[Antilymphocyte globulins and neoplastic disease]D Mazzei, G Luporini
Giornale Italiano Di Chemioterapia|January 1, 1982
[The use of oral futraful as secondary treatment of patients with metastatic carcinoma]R Labianca, G Beretta, G Luporini
Journal of Surgical Oncology. Supplement|January 1, 1993
Medical treatment of hepatocellular carcinomaG Luporini, R Labianca, G Pancera
Journal of Surgical Oncology. Supplement|January 1, 1991
Chemotherapy for patients not benefitting from 5-fluorouracil therapyG Luporini, R Labianca, G Pancera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Factors influencing response rates for advanced colorectal cancer chemotherapyR Labianca, G Pancera, G Luporini
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Cisplatinum based chemotherapy: role of the antiserotoninergic ondansetron in prevention of emesisM C Locatelli, A D'Antona, G Luporini
Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report)G Luporini, P Fraschini, R Labianca, et al.
Lancet (London, England)|April 2, 1977
Carcinoembryonic antigen revisitedG Luporini, P Fraschini, R Labianca, et al.
Pageof 6